AzTrials
AzTrials

Acute Abdomen in ChildrenEchoPrémANCT07275268

DIAGNOSTIC CONTRIBUTION OF EARLY ABDOMINAL ULTRASOUND IN THE SITUATION OF ACUTE ABDOMEN OF PREMATURE

A study testing Abdominal Ultrasound in people with Acute Abdomen in Children, run by Centre Hospitalier Universitaire de Besancon.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study will assess the diagnostic contribution of early abdominal ultrasound for acute abdomen in premature newborns. Early ultrasound assessment would provide diagnostic assistance, in conjunction with clinical examination and biological testing, in the three main clinical situations encountered with an acute… Read more about this study

Who is it for?
Ages Up to 36 weeks
Conditions the study is for
Acute Abdomen in Children
What is being tested?
Abdominal Ultrasound
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
No sites listed yet
Study dates
Dec 2025to Jun 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 36 weeks
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Premature under 37 weeks of amenorrhea with an adverse event of special interest such as :
  • altered abdomen with bloating or presence of previsouly unknow marked collateral circulation,
  • absence of spontaneous transit (> 48 hours),
  • episode of rectal bleeding,
  • repeated regurgitation/vomiting (during more than 50% of feedings),
  • prolonged fasting (>12 hours), OR
  • increase in cardiorespiratory events on continuous monitoring associated with one of the elements listed above.

Who cannot join

  • organic malformation detected during prenatal monitoring or discovered in the immediate postnatal period,
  • chromosomal abnormality detected during prenatal monitoring or discovered in the immediate postnatal period,- spontaneous perforation occurring during the first week of life.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Morgane VIDONI AGUILAR, Int contact

0033 3 81 21 91 61

maguilarrubio@chu-besancon.fr

About this study

This study will assess the diagnostic contribution of early abdominal ultrasound for acute abdomen in premature newborns.

Early ultrasound assessment would provide diagnostic assistance, in conjunction with clinical examination and biological testing, in the three main clinical situations encountered with an acute abdomen in premature infants: enterocolitis (digestive translocation of a bacterium secondary to inflammation, local fragility of the digestive tract, associated ischemic phenomena), reflex ileus (decrease in intestinal peristalsis secondary to peritoneal reactivity following inflammatory phenomena) and digestive immaturity (expressed by bloating, regurgitation, absence of spontaneous transit, related to the degree of prematurity).

Being tested
Abdominal Ultrasound

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Abdominal UltrasoundProcedure or surgery

    Abdominal Ultrasound

Study groups in NCT07275268
Study groupRoleWhat they receive
Abdominal UltrasoundExperimentalAbdominal Ultrasound
Receives: Procedure: Abdominal Ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Presence or absence of echographic signs

    Presence of "positive" echographic signs such as:

    aeroportia, pneumatosis parietalis, pneumoperitoneum, bowel wall thickening, fluid effusion, distension of bowel loops, during the early echography for premature newborns with digestive symptomatology.

    Measured: Day 5

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Dec 2025
  2. Study startDec 2025 (estimated)
  3. Primary completionJun 2028 (estimated)
  4. Study completionJun 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07275268
Sponsor's protocol ID
2025/979
Acronym
EchoPrémA
Status last verified
Nov 2025
First submitted
28 Nov 2025
Last updated
10 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Abdominal Ultrasound in people with Acute Abdomen in Children, run by Centre Hospitalier Universitaire de Besancon.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 10 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Morgane VIDONI AGUILAR, Int (0033 3 81 21 91 61, maguilarrubio@chu-besancon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Presence or absence of echographic signs (time frame: Day 5). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in